Multifocal G1-G2 gastric neuroendocrine tumors: Differentiating between Type I, II and III, a clinicopathologic review

doi:10.12998/wjcc.v7.i17.2413

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 17

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11119)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

573

WORD

298

HTML

4451

Figures (1-2)

670

Tables (1-2)

655

Sum=6647

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

833

Download

1105

Sum=1938

Publishing Process of This Article

Item

Count

Browse

981

Download

1556

Sum=2537

Sep 6, 2019 (publication date) through Feb 23, 2026

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Minireviews

World J Clin Cases. Sep 6, 2019; 7(17): 2413-2419
Published online Sep 6, 2019. doi: 10.12998/wjcc.v7.i17.2413

Multifocal G1-G2 gastric neuroendocrine tumors: Differentiating between Type I, II and III, a clinicopathologic review

Khaled Algashaamy, Monica Garcia-Buitrago

Khaled Algashaamy, Monica Garcia-Buitrago, Department of Pathology and Laboratory Medicine, Jackson Memorial Hospital, University of Miami, Miller School of Medicine, Miami, FL 33136, United States

Author contributions: Algashaamy K and Garcia-Buitrago M wrote this review.

Conflict-of-interest statement: The authors have nothing to disclose.

Corresponding author: Khaled Algashaamy, MBBS, MD, Doctor, Department of Pathology and Laboratory Medicine, Jackson Memorial Hospital, University of Miami, Miller School of Medicine, Holtz Center, 1611 NW 12th Avenue, Suite 2044, Miami, FL 33136, United States. khaled.algashaamy@jhsmiami.org

Received: April 23, 2019
Peer-review started: May 8, 2019
First decision: May 31, 2019
Revised: July 26, 2019
Accepted: August 20, 2019
Article in press: August 20, 2019
Published online: September 6, 2019
Processing time: 137 Days and 9.6 Hours

Core Tip

Core tip: Gastric neuroendocrine tumors are a rare entity with increasing incidence. Different pathophysiological processes can lead to the development of these tumors, appropriate histological analysis is necessary to differentiate between grade 1 (G1) and grade 2 (G2) tumors as this will impact the management of these patients based on their increased risk of lymph node and distant metastases. In this mini-review article, we aim to provide a comprehensive clinicopathologic review of multifocal gastric neuroendocrine tumors, with particular emphasis on G1 and G2 tumors and differentiating between types I, II and II and risk stratification based upon immunohistochemical profile. We have based this review on peer-reviewed literature and the authors’ experience.